Susquehanna International Group’s AVEO Pharmaceuticals, Inc. AVEO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-19,000
| Closed | -$156K | – | 14687 |
|
|
2022
Q3 | $156K | Sell |
19,000
-17,900
| -49% | -$137K | ﹤0.01% | 11183 |
|
|
2022
Q2 | $242K | Sell |
36,900
-46,900
| -56% | -$227K | ﹤0.01% | 10153 |
|
|
2022
Q1 | $468K | Sell |
83,800
-98,900
| -54% | -$407K | ﹤0.01% | 9167 |
|
|
2021
Q4 | $857K | Buy |
182,700
+23,000
| +14% | +$143K | ﹤0.01% | 7706 |
|
|
2021
Q3 | $987K | Sell |
159,700
-98,600
| -38% | -$590K | ﹤0.01% | 7586 |
|
|
2021
Q2 | $1.7M | Buy |
258,300
+21,800
| +9% | +$150K | ﹤0.01% | 6302 |
|
|
2021
Q1 | $1.73M | Buy |
236,500
+61,300
| +35% | +$529K | ﹤0.01% | 6270 |
|
|
2020
Q4 | $1.01M | Sell |
175,200
-22,800
| -12% | -$131K | ﹤0.01% | 6707 |
|
|
2020
Q3 | $1.18M | Sell |
198,000
-55,600
| -22% | -$275K | ﹤0.01% | 5728 |
|
|
2020
Q2 | $1.31M | Sell |
253,600
-14,300
| -5% | -$90.3K | ﹤0.01% | 5321 |
|
|
2020
Q1 | $970K | Buy |
267,900
+230,240
| +611% | +$1.14M | ﹤0.01% | 5483 |
|
|
2019
Q4 | $235K | Sell |
37,660
-65,880
| -64% | -$485K | ﹤0.01% | 8478 |
|
|
2019
Q3 | $874K | Buy |
103,540
+18,600
| +22% | +$138K | ﹤0.01% | 5975 |
|
|
2019
Q2 | $572K | Buy |
84,940
+18,250
| +27% | +$156K | ﹤0.01% | 7005 |
|
|
2019
Q1 | $547K | Sell |
66,690
-2,100
| -3% | -$21.7K | ﹤0.01% | 6093 |
|
|
2018
Q4 | $1.1M | Buy |
68,790
+20,590
| +43% | +$453K | ﹤0.01% | 4498 |
|
|
2018
Q3 | $1.59M | Buy |
48,200
+9,650
| +25% | +$248K | ﹤0.01% | 4365 |
|
|
2018
Q2 | $871K | Buy |
38,550
+1,850
| +5% | +$43.9K | ﹤0.01% | 5651 |
|
|
2018
Q1 | $1.06M | Buy |
36,700
+6,890
| +23% | +$202K | ﹤0.01% | 5110 |
|
|
2017
Q4 | $832K | Buy |
29,810
+10,110
| +51% | +$314K | ﹤0.01% | 5613 |
|
|
2017
Q3 | $719K | Buy |
19,700
+18,100
| +1,131% | +$560K | ﹤0.01% | 5882 |
|
|
2017
Q2 | $36K | Buy |
+1,600
| New | +$12.6K | ﹤0.01% | 8954 |
|
|
2015
Q4 | – | Sell |
-2,910
| Closed | -$35K | – | 10249 |
|
|
2015
Q3 | $35K | Sell |
2,910
-860
| -23% | -$12.4K | ﹤0.01% | 9431 |
|
|
2015
Q2 | $66K | Sell |
3,770
-4,200
| -53% | -$75.6K | ﹤0.01% | 9813 |
|
|
2015
Q1 | $116K | Sell |
7,970
-1,280
| -14% | -$14K | ﹤0.01% | 8918 |
|
|
2014
Q4 | $78K | Sell |
9,250
-1,650
| -15% | -$15.1K | ﹤0.01% | 9264 |
|
|
2014
Q3 | $121K | Buy |
10,900
+6,460
| +145% | +$82.1K | ﹤0.01% | 9017 |
|
|
2014
Q2 | $81K | Buy |
4,440
+2,600
| +141% | +$33.8K | ﹤0.01% | 9484 |
|
|
2014
Q1 | $28K | Buy |
+1,840
| New | +$33K | ﹤0.01% | 8765 |
|
|
2013
Q4 | – | Sell |
-8,060
| Closed | -$167K | – | 9507 |
|
|
2013
Q3 | $167K | Buy |
8,060
+1,510
| +23% | +$34.6K | ﹤0.01% | 7874 |
|
|
2013
Q2 | $164K | Buy |
+6,550
| New | +$280K | ﹤0.01% | 7576 |
|
Susquehanna International Group's AVEO Position: Q1 2023 in Review
Susquehanna International Group sold out of AVEO Pharmaceuticals, Inc. (AVEO) in Q1 2023, closing a stake of 439,159 shares — an estimated $6.57M sold.
Susquehanna International Group first reported a position in AVEO in Q2 2013 and held it in 31 quarters. The position peaked at $6.57M in Q4 2022. 0 funds tracked by Wall St. Rank hold AVEO as of Q1 2023.
- Susquehanna International Group reported no remaining AVEO Pharmaceuticals, Inc. position as of Q1 2023 after selling out during the quarter.
- Susquehanna International Group sold 439,159 AVEO Pharmaceuticals, Inc. shares in Q1 2023, an estimated $6.57M.
- Susquehanna International Group first reported a position in AVEO Pharmaceuticals, Inc. in Q2 2013 and held it in 31 quarters.
- Susquehanna International Group's AVEO Pharmaceuticals, Inc. position peaked at $6.57M in Q4 2022.
- 0 funds tracked by Wall St. Rank held AVEO Pharmaceuticals, Inc. as of Q1 2023.
Based on Susquehanna International Group's 13F filing for Q1 2023, filed 16 May 2023.